{
  "resourceType": "Bundle",
  "type": "document",
  "entry": [
    {
      "resource": {
        "resourceType": "Patient",
        "id": "patient-1",
        "gender": "female",
        "birthDate": "2004"
      }
    },
    {
      "resource": {
        "resourceType": "Condition",
        "id": "condition-1",
        "clinicalStatus": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code": "active"
            }
          ]
        },
        "verificationStatus": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/condition-ver-status",
              "code": "confirmed"
            }
          ]
        },
        "code": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "449868002",
              "display": "Hereditary antithrombin III deficiency"
            }
          ],
          "text": "Hereditary antithrombin (AT) deficiency"
        },
        "subject": {
          "reference": "Patient/patient-1"
        }
      }
    },
    {
      "resource": {
        "resourceType": "Condition",
        "id": "condition-2",
        "clinicalStatus": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/condition-clinical",
              "code": "resolved"
            }
          ]
        },
        "verificationStatus": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/condition-ver-status",
              "code": "confirmed"
            }
          ]
        },
        "code": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "161765003",
              "display": "Spontaneous abortion - complete"
            }
          ],
          "text": "Previous two first-trimester pregnancy losses"
        },
        "subject": {
          "reference": "Patient/patient-1"
        }
      }
    },
    {
      "resource": {
        "resourceType": "Procedure",
        "id": "procedure-1",
        "status": "completed",
        "code": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "90460007",
              "display": "Caesarean section"
            }
          ],
          "text": "Cesarean section"
        },
        "subject": {
          "reference": "Patient/patient-1"
        },
        "performedPeriod": {
          "start": "2023-10-01",
          "end": "2023-10-01"
        }
      }
    },
    {
      "resource": {
        "resourceType": "MedicationStatement",
        "id": "medication-1",
        "status": "active",
        "medicationCodeableConcept": {
          "coding": [
            {
              "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
              "code": "583214",
              "display": "Heparin Sodium"
            }
          ],
          "text": "Low molecular weight heparin (LMWH)"
        },
        "subject": {
          "reference": "Patient/patient-1"
        },
        "dosage": [
          {
            "text": "adjusted dose throughout pregnancy"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "MedicationStatement",
        "id": "medication-2",
        "status": "completed",
        "medicationCodeableConcept": {
          "coding": [
            {
              "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
              "code": "1668705",
              "display": "Antithrombin III, human"
            }
          ],
          "text": "Kybernin P (human AT III concentrate)"
        },
        "subject": {
          "reference": "Patient/patient-1"
        },
        "dosage": [
          {
            "text": "prophylactically prior to delivery"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "MedicationStatement",
        "id": "medication-3",
        "status": "active",
        "medicationCodeableConcept": {
          "coding": [
            {
              "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
              "code": "1668705",
              "display": "Tinzaparin"
            }
          ],
          "text": "Tinzaparin"
        },
        "subject": {
          "reference": "Patient/patient-1"
        },
        "dosage": [
          {
            "text": "4500 IU daily for 6 weeks postpartum"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "Observation",
        "id": "observation-1",
        "status": "final",
        "code": {
          "coding": [
            {
              "system": "http://loinc.org",
              "code": "3176-8",
              "display": "D-Dimer"
            }
          ],
          "text": "D-dimers"
        },
        "subject": {
          "reference": "Patient/patient-1"
        },
        "effectivePeriod": {
          "start": "2023-07-01",
          "end": "2023-10-01"
        }
      }
    },
    {
      "resource": {
        "resourceType": "Observation",
        "id": "observation-2",
        "status": "final",
        "code": {
          "coding": [
            {
              "system": "http://loinc.org",
              "code": "27821-0",
              "display": "Antithrombin III activity"
            }
          ],
          "text": "AT activity"
        },
        "subject": {
          "reference": "Patient/patient-1"
        },
        "effectivePeriod": {
          "start": "2023-07-01",
          "end": "2023-10-01"
        }
      }
    },
    {
      "resource": {
        "resourceType": "Observation",
        "id": "observation-3",
        "status": "final",
        "code": {
          "coding": [
            {
              "system": "http://loinc.org",
              "code": "49068-4",
              "display": "Factor Xa Inhibitor"
            }
          ],
          "text": "Anti-Xa measurements"
        },
        "subject": {
          "reference": "Patient/patient-1"
        },
        "effectivePeriod": {
          "start": "2023-07-01",
          "end": "2023-10-01"
        }
      }
    },
    {
      "resource": {
        "resourceType": "CarePlan",
        "id": "careplan-1",
        "status": "active",
        "intent": "plan",
        "title": "Management of Hereditary Antithrombin (AT) Deficiency",
        "description": "Plan for managing hereditary antithrombin (AT) deficiency including medication, monitoring, and follow-up.",
        "subject": {
          "reference": "Patient/patient-1"
        },
        "activity": [
          {
            "detail": {
              "kind": "MedicationRequest",
              "code": {
                "coding": [
                  {
                    "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
                    "code": "583214",
                    "display": "Heparin Sodium"
                  }
                ],
                "text": "Low molecular weight heparin (LMWH)"
              },
              "description": "Continue adjusted dose of low molecular weight heparin (LMWH) throughout pregnancy"
            }
          },
          {
            "detail": {
              "kind": "Observation",
              "code": {
                "coding": [
                  {
                    "system": "http://loinc.org",
                    "code": "3176-8",
                    "display": "D-Dimer"
                  }
                ],
                "text": "Monitor monthly with d-dimers"
              }
            }
          },
          {
            "detail": {
              "kind": "Observation",
              "code": {
                "coding": [
                  {
                    "system": "http://loinc.org",
                    "code": "27821-0",
                    "display": "Antithrombin III activity"
                  }
                ],
                "text": "Monitor monthly with AT activity"
              }
            }
          },
          {
            "detail": {
              "kind": "Observation",
              "code": {
                "coding": [
                  {
                    "system": "http://loinc.org",
                    "code": "49068-4",
                    "display": "Factor Xa Inhibitor"
                  }
                ],
                "text": "Monitor monthly with anti-Xa measurements"
              }
            }
          },
          {
            "detail": {
              "kind": "MedicationRequest",
              "code": {
                "coding": [
                  {
                    "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
                    "code": "1668705",
                    "display": "Antithrombin III, human"
                  }
                ],
                "text": "Manage with Kybernin P (human AT III concentrate) prophylactically"
              },
              "description": "Manage with Kybernin P (human AT III concentrate) prophylactically to overcome the risk of thrombosis"
            }
          },
          {
            "detail": {
              "kind": "Observation",
              "code": {
                "coding": [
                  {
                    "system": "http://loinc.org",
                    "code": "27821-0",
                    "display": "Antithrombin III activity"
                  }
                ],
                "text": "Functional AT levels"
              },
              "description": "Functional AT levels were measured daily prior to each dose of AT and levels were maintained between 60 and 100%"
            }
          },
          {
            "detail": {
              "kind": "MedicationRequest",
              "code": {
                "coding": [
                  {
                    "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
                    "code": "1668705",
                    "display": "Tinzaparin"
                  }
                ],
                "text": "Tinzaparin"
              },
              "description": "Discharge with tinzaparin 4500 IU daily for 6 weeks postpartum"
            }
          }
        ]
      }
    }
  ]
}